Charred food may be one of the latest fads at fashionable restaurants—at least according to the New York Times food section—but there seems to be a dark side to this trend.
A malaria drug is doing something it's never done before: treat brain cancer.
The U.S. cancer mortality rate, in steady decline for over three decades, still takes a higher toll on African Americans. Regional disparities persist, too, with some areas of the country seeing worsening cancer mortality rates.
Cancer deaths have declined in the U.S. over the past three decades, but mortality rates can vary greatly depending on the county where you live. Researchers say that information could better inform treatment and prevention efforts in certain communities.
Dr. Gilbert Padula is Summa Health System's new medical director for the Summa Health Cancer Institute, starting Jan. 30.
BioMotiv, a Cleveland-based drug development accelerator associated with The Harrington Project, and a university in New Zealand have announced the formation of an immuno-oncology startup that will work to develop a suite of cancer vaccines.
Blue Cross and Blue Shield of Michigan has cut expenses by $106.5 million since it announced its three-year strategic business transformation project in November 2015 and said it is on-pace to cut a total of $300 million by 2019.
Scientists at Northwestern's Lurie Cancer Center will be able to access new therapies developed by North Chicago-based AbbVie which can exclusively license any discoveries made during the collaboration.
Cancer patients with Medicaid coverage receive poorer quality and less healthcare than those with employer-sponsored, Medicare or other private insurance. Medicaid benefits vary from state by state and experts say that inequality will likely grow under the Trump administration.
Links between community hospitals and cancer centers can lead to better care and a better bottom line. Many regard these relationships as necessary to preserve quality and expand access to state-of-the-art oncology care.
Dr. Judith Salerno is stepping down as president and CEO of the breast cancer research group to pursue new opportunities. Susan G. Komen's general counsel, Ellen Wilmott, will step into the role on an interim basis.
A provision of Amendment 3 would have hurt Big Tobacco's smaller rivals by imposing an additional 67-cent-per-pack tax—on top of the 60-cent hike imposed on the major brands—on discount cigarette brands left out of a 1998 tobacco lawsuit settlement. In the settlement, the major tobacco...